A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

Clinical trial NCT07532603 · RECRUITING

Trial details

NCT number: NCT07532603
Sponsor: Priovant Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lichen Planopilaris

Start date: 2026-03-19
Primary completion: 2028-12-31
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.